Ostatné · BRKR
Bruker Corporation
Fundamenty firmy Healthcare · Medical Devices · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 12 hodnotení
nákup
- Najnižší cieľ
- 50,00
- Priemerný cieľ
- 62,25
- Najvyšší cieľ
- 80,00
- Potenciál
- −2,2 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | 0,42 | 0,39–0,45 | 0,45 | −7,4 % |
| budúci štvrťrok | 0,90 | 0,88–0,91 | 0,59 | +53,0 % |
| tento rok | 2,12 | 2,10–2,13 | 1,83 | +15,9 % |
| budúci rok | 2,39 | 2,17–2,53 | 2,12 | +12,8 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 865,3 mil. | 860,5 mil. | +0,6 % |
| budúci štvrťrok | 1,0 mld. | 977,2 mil. | +5,2 % |
| tento rok | 3,6 mld. | 3,4 mld. | +3,5 % |
| budúci rok | 3,7 mld. | 3,6 mld. | +4,2 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Munch Mark RobertOfficer | uplatnenie opcií | 44 380 | 15.09. |
| Munch Mark RobertOfficer | predaj | 105 740 | 15.09. |
| Munch Mark RobertOfficer | uplatnenie opcií | 44 380 | 14.08. |
| Bures ThomasOfficer | odmena v akciách | – | 14.08. |
| Laukien Frank HChief Executive Officer | odmena v akciách | – | 14.08. |
| Munch Mark RobertOfficer | odmena v akciách | – | 14.08. |
| Prause BurkhardOfficer | odmena v akciách | – | 14.08. |
| Srega JuergenOfficer | odmena v akciách | – | 14.08. |
| Herman Gerald NChief Financial Officer | odmena v akciách | – | 14.08. |
| Munch Mark RobertOfficer | predaj | 115 200 | 14.08. |
| Munch Mark RobertOfficer | uplatnenie opcií | 44 380 | 15.07. |
| Munch Mark RobertOfficer | predaj | 120 500 | 15.07. |
Kto vlastní akcie
Slávni investori: Ray Dalio · 0.0 % · nový
FMR, LLC13,28 %
Orbis Allan Gray Ltd11,77 %
Blackrock Inc.7,49 %
Pallas Capital Advisors Llc6,22 %
Vanguard Portfolio Management LLC3,21 %
Vanguard Capital Management LLC3,19 %
Sculptor Capital LP3,04 %
State Street Corporation2,64 %
O firme (popis z Yahoo Finance, anglicky)
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
Technické signály
- Rastový trend – Kurz nad SMA50 aj SMA200, SMA50 nad SMA200
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou BRKR.